SW
RMD icon

SlateStone Wealth’s ResMed RMD Stock Holding History

SlateStone Wealth’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.56M Sell
13,152
-3,232
-20% -$670K 0.2% 97
2026
Q1 		$3.68M Buy
16,384
+1,303
+9% +$325K 0.3% 80
2025
Q4 		$3.63M Sell
15,081
-19
-0.1% -$4.86K 0.3% 79
2025
Q3 		$4.13M Buy
15,100
+1,008
+7% +$275K 0.36% 73
2025
Q2 		$3.64M Buy
14,092
+869
+7% +$207K 0.34% 76
2025
Q1 		$2.96M Buy
13,223
+977
+8% +$228K 0.3% 83
2024
Q4 		$2.8M Buy
12,246
+696
+6% +$168K 0.27% 86
2024
Q3 		$2.82M Buy
11,550
+1,152
+11% +$257K 0.25% 88
2024
Q2 		$1.99M Buy
10,398
+1,112
+12% +$226K 0.22% 96
2024
Q1 		$1.84M Buy
9,286
+1,108
+14% +$203K 0.18% 102
2023
Q4 		$1.41M Sell
8,178
-910
-10% -$140K 0.18% 103
2023
Q3 		$1.34M Buy
9,088
+876
+11% +$158K 0.2% 101
2023
Q2 		$1.79M Buy
8,212
+118
+1% +$26.3K 0.34% 65
2023
Q1 		$1.77M Buy
8,094
+1,559
+24% +$338K 0.37% 61
2022
Q4 		$1.36M Buy
6,535
+1,101
+20% +$242K 0.33% 71
2022
Q3 		$1.19M Buy
+5,434
New +$1.24M 0.32% 69

Other funds holding RMD

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
AT
Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM
AS
Aware Super Sydney, Australia $7.06B AUM
TIM
Triodos Investment Management Driebergen-Rijsenburg, Netherlands $1.64B AUM 37.98% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
WTA
Washington Trust Advisors Wellesley, Massachusetts $1.35B AUM 28.4% 1-Year Est. Return
CISOA
Capital Investment Services of America Milwaukee, Wisconsin $1.02B AUM 3.04% 1-Year Est. Return
DJSG
D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

SlateStone Wealth's RMD Position: Q2 2026 in Review

SlateStone Wealth reduced its ResMed (RMD) stake by 20% in Q2 2026, selling an estimated $670K and leaving 13,152 shares worth $2.56M. The position accounts for 0.2% of the portfolio, ranked #97.

SlateStone Wealth first reported a position in RMD in Q3 2022 and has held it in 16 quarters since. The position peaked at $4.13M in Q3 2025. 279 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • SlateStone Wealth held 13,152 shares of ResMed worth $2.56M as of Q2 2026.
  • SlateStone Wealth sold 3,232 ResMed shares in Q2 2026, an estimated $670K.
  • ResMed made up 0.2% of SlateStone Wealth's portfolio in Q2 2026, its #97 holding.
  • SlateStone Wealth first reported a position in ResMed in Q3 2022 and has held it in 16 quarters since.
  • SlateStone Wealth's ResMed position peaked at $4.13M in Q3 2025.
  • 279 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on SlateStone Wealth's 13F filing for Q2 2026, filed 20 Jul 2026.